Pore Refining Toner

Manufacturer
Private Label Skin Care
Effective date
2025-02-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:57:00

Label at a glance#

ProductPore Refining Toner
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

• for the treatment of acne

Dosage and administration

• Spray toner directly on face or on cotton pad. Apply to face and neck, avoiding eye area. Repeat until minimal dirt is visible. Can be used twice daily or as directed.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses 

INDICATIONS & USAGE SECTION

• for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • avoid contact with eyes, lips and mouth. If contact occurs, flush thoroughly with water.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

• Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• Spray toner directly on face or on cotton pad. Apply to face and neck, avoiding eye area. Repeat until minimal dirt is visible. Can be used twice daily or as directed.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, Propanediol, Glycerin, 1,2-Hexanediol, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Sodium Hydroxide, Menthyl Lactate, Allantoin, Rosemary (Rosmarinus Officinalis) Leaf Extract, Olive (Olea Europaea) Leaf Extract, Papaya (Carica Papaya) Fruit Extract, Sodium PCA, Caprylhydroxamic Acid, Panthenol, Peppermint (Mentha Piperita) Oil, Citric Acid, Oat (Avena Sativa) Bran Extract

SPL UNCLASSIFIED SECTION

brand MD

Allantoin
Papaya
Oat Bran

MEDICAL GRADE

PREPARE

RECOMMENDED FOR

• BLEMISH-PRONE
• COMBO   • OILY

GREEN LEAF PROGRAM

NOT TESTED ON ANIMALS

Distributed by:
brandMD®
Canoga Park, CA 91304
(818) 534-3180
www.brandMD.com

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Pore Refining TonerPore Refining Toner

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
251577salicylic acid 2 % Topical SolutionPSN1
251577salicylic acid 20 MG/ML Topical SolutionSCD1
251577salicylic acid 2 % Topical SolutionSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72957-013-01Pore Refining Toner195 g in 1 BOTTLE, SPRAYLIQUID1951

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72957-013PORE REFINING TONER (SALICYLIC ACID) LIQUID [PRIVATE LABEL SKIN CARE]1Current NDC, 1 package rows20250313_93db4294-3422-478e-a82e-122b39cac288.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72957-01372957-013-01
39765-017

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pore Refining TonerSALICYLIC ACIDPrivate Label Skin Care93db4294-3422-478e-a82e-122b39cac2882025-02-27WarningsExact identifier
ndc (package): 72957-013-01
ndc (product): 72957-013
ndc11 (package): 72957001301
spl id: a17e3522-6e7a-4b3f-81ee-34b465468c0b
spl set id: 93db4294-3422-478e-a82e-122b39cac288

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.